In this on demand webinar with Liza Wijler, an authority in the field of organoid drug discovery, learn about the innovations that are setting new standards for preclinical anticancer drug screening.
Topics covered include patient-derived organoids and patient-derived xenograft–derived organoids; a detailed case study comparing an assay-ready organoid platform to traditional models; ways advanced organoid models can be leveraged for large-scale studies; and more.
Watch Now